Literature DB >> 1693200

Recurrent symptoms after ventricular pacing in unexplained syncope.

A P Fitzpatrick1, C M Travill, P E Vardas, W N Hubbard, A Wood, A Ingram, R Sutton.   

Abstract

We report clinical and hemodynamic data in two cases of recurrent syncope. Both patients received permanent demand ventricular pacing (VVI) for unexplained syncope. Both patients experienced recurrent syncope after pacemaker implantation. They later underwent 60 degrees head-up tilt testing, initially noninvasively and then with hemodynamic profile. A vasovagal response to tilt occurred with bradycardia and was complicated by the onset of ventricular pacing and retrograde atrioventricular conduction (RAVC) with hemodynamic deterioration and rapid reproduction of syncope. Limited intracardiac electrophysiological study (EPS) excluded atrioventricular (AV) conduction disease, sinus node disease, and carotid sinus syndrome, and confirmed RAVC. Both patients were upgraded to dual chamber pacing, DDI mode, with 50/80 rate hysteresis. One patient was asymptomatic at repeat tilt testing; the other experienced continued symptoms due to the vasodepressor component of vasovagal syncope. Cardiac pacing alone is ineffective treatment for this phenomenon, and no proven therapy is presently available. Ventricular pacing applied to patients with unexplained syncope may lead to an increase in or continuation of symptoms rather than an amelioration. There is a need for full investigation of such patients, which must include tilt testing, to allow for the most accurate diagnosis possible and guide the most appropriate therapy.

Entities:  

Mesh:

Year:  1990        PMID: 1693200     DOI: 10.1111/j.1540-8159.1990.tb02078.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

Review 1.  Can cardiac pacing prevent neurocardiogenic syncope?

Authors:  A K Gupta; A Maheshwari; R K Thakur; C P Shah; Y Y Lokhandwala
Journal:  J Interv Card Electrophysiol       Date:  2001-12       Impact factor: 1.900

Review 2.  Emerging indications for permanent pacing.

Authors:  D L Wolbrette; G V Naccarelli
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

Review 3.  Has cardiac pacing a role in vasovagal syncope?

Authors:  Richard Sutton
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 4.  Pacemaker syndrome: an iatrogenic condition.

Authors:  C M Travill; R Sutton
Journal:  Br Heart J       Date:  1992-08

Review 5.  Basics of cardiac pacing: selection and mode choice.

Authors:  John M Morgan
Journal:  Heart       Date:  2006-06       Impact factor: 5.994

6.  Recommendations for pacemaker prescription for symptomatic bradycardia. Report of a working party of the British Pacing and Electrophysiology Group.

Authors: 
Journal:  Br Heart J       Date:  1991-08

7.  Permanent pacing for cardioinhibitory malignant vasovagal syndrome.

Authors:  M E Petersen; R Chamberlain-Webber; A P Fitzpatrick; A Ingram; T Williams; R Sutton
Journal:  Br Heart J       Date:  1994-03

8.  Pacing for vasovagal syncope.

Authors:  Nevin T Wijesekera; Arvinder S Kurbaan
Journal:  Indian Pacing Electrophysiol J       Date:  2002-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.